Journal of Neuroimmunology

Article	Citations
SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation	86
A systematic review of cases of CNS demyelination following COVID-19 vaccination	76
A case of longitudinally extensive transverse myelitis following vaccination against Covid-19	71
The emerging role of the BDNF-TrkB signaling pathway in the modulation of pain perception	66
Safety and efficacy of COVID-19 vaccines in multiple sclerosis patients	62
Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: Up to 6 months cross-sectional study	61
The pathogenic, therapeutic and diagnostic role of exosomal microRNA in the autoimmune diseases	58
Neurological manifestations of COVID-19: A comprehensive literature review and discussion of mechanisms	50
Inflammation in Huntington's disease: A few new twists on an old tale	50
Stress and cancer. Part I: Mechanisms mediating the effect of stressors on cancer	48
The neutrophil-to-lymphocyte ratio in Alzheimer's disease: Current understanding and potential applications	46
Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature	42
Involvement of NFƙB and MAPK signaling pathways in the preventive effects of Ganoderma lucidum on the inflammation of BV-2 microglial cells induced by LPS	40
Stellate ganglion block reduces symptoms of Long COVID: A case series	40
Fasudil inhibits the activation of microglia and astrocytes of transgenic Alzheimer's disease mice via the downregulation of TLR4/Myd88/NF-κB pathway	36
New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure	34
AstraZeneca COVID-19 vaccine and Guillain- Barré Syndrome in Tasmania: A causal link?	34
Toll-like receptors in Alzheimer's disease	34
Acute transverse myelitis with Dysautonomia following SARS-CoV-2 infection: A case report and review of literature	33
COVID-19-related encephalopathy presenting with aphasia resolving following tocilizumab treatment	32
Guillain-Barré syndrome in a patient infected with SARS-CoV-2, a case report	32
Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement	32
MyD88-dependent and -independent signalling via TLR3 and TLR4 are differentially modulated by Δ9-tetrahydrocannabinol and cannabidiol in human macrophages	32
Multipotential and systemic effects of traumatic brain injury	31
Hyperacute reversible encephalopathy related to cytokine storm following COVID-19 vaccine	31

The role of damage associated molecular pattern molecules (DAMPs) and permeability of the blood-brain barrier in depression and neuroinflammation	31
A selective NLRP3 inflammasome inhibitor attenuates behavioral deficits and neuroinflammation in a mouse model of Parkinson's disease	30
Searching for autoimmune encephalitis: Beware of normal CSF	30
The involvement of JAK/STAT signaling pathway in the treatment of Parkinson's disease	28
Modulation of the HMGB1/TLR4/NF-κB signaling pathway in the CNS by matrine in experimental autoimmune encephalomyelitis	28
The microglial NLRP3 inflammasome is involved in human SARS-CoV-2 cerebral pathogenicity: A report of three post-mortem cases	27
Acute myelitis and ChAdOx1 nCoV-19 vaccine: Casual or causal association?	27
Anti-MAG neuropathy: From biology to clinical management	26
LncRNA NEAT1/miR-128-3p/AQP4 axis regulating spinal cord injury-induced neuropathic pain progression	26
A case of area postrema variant of neuromyelitis optica spectrum disorder following SARS-CoV-2 infection	26
Clinical, neuroradiological, diagnostic and prognostic profile of autoimmune glial fibrillary acidic protein astrocytopathy: A pooled analysis of 324 cases from published data and a single-center retr	26
Association of Guillain-Barre syndrome with COVID-19 infection: An updated systematic review	26
Probiotics protect against gut dysbiosis associated decline in learning and memory	26
Hemorrhagic encephalopathy associated with COVID-19	25
Stiff person syndrome spectrum disorders; more than meets the eye	25
Risk factors of attacks in neuromyelitis optica spectrum disorders	24
Knockdown of miR-130a-3p alleviates spinal cord injury induced neuropathic pain by activating IGF-1/IGF-1R pathway	24
Cerebrospinal fluid immune markers and HIV-associated neurocognitive impairments: A systematic review	24
Neuroinflammation and fibrosis in stroke: The good, the bad and the ugly	23
Herpesviruses and the hidden links to Multiple Sclerosis neuropathology	23
The neuropsychological spectrum of anti-LGI1 antibody mediated autoimmune encephalitis	23
Acute disseminated encephalomyelitis and COVID-19: A systematic synthesis of worldwide cases	22
The peripheral blood immune cell profile in a teriflunomide-treated multiple sclerosis patient with COVID-19 pneumonia	21
Salivary GFAP as a potential biomarker for diagnosis of mild cognitive impairment and Alzheimer's disease and its correlation with neuroinflammation and apoptosis	21
New-onset refractory status epilepticus following the ChAdOx1 nCoV-19 vaccine	21
NMOSD acute attack: Understanding, treatment and innovative treatment prospect	21
Sensitivity and specificity of a commercial ELISA test for anti-MAG antibodies in patients with neuropathy	21
COVID-19, HHV6 and MOG antibody: A perfect storm	21
Disease-modifying therapies and progressive multifocal leukoencephalopathy in multiple sclerosis: A systematic review and meta-analysis	20
Thyroid hormone and thyromimetics inhibit myelin and axonal degeneration and oligodendrocyte loss in EAE	20
The emerging role of lncRNAs in multiple sclerosis	20
Gut microbial metabolite TMAO portends prognosis in acute ischemic stroke	19
Longitudinally extensive transverse myelitis with anti-myelin oligodendrocyte glycoprotein antibodies following SARS-CoV-2 infection	19
Immunologic characterization of a immunosuppressed multiple sclerosis patient that recovered from SARS-CoV-2 infection	19
Aseptic meningitis and leptomeningeal enhancement associated with anti-MOG antibodies: A review	19
Safety and efficacy of rituximab for relapse prevention in myelin oligodendrocyte glycoprotein immunoglobulin G (MOG-IgG)-associated disorders (MOGAD): A systematic review and meta-analysis	18
Stress and cancer. Part II: Therapeutic implications for oncology	18
Initial clinical manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine	18
The second brain: The connection between gut microbiota composition and multiple sclerosis	18
Protective effect of scorpion venom heat-resistant synthetic peptide against PM2.5-induced microglial polarization via TLR4-mediated autophagy activating PI3K/AKT/NF-κB signaling pathway	17
Efficacy of low dose rituximab in treatment-resistant CIDP with antibodies against NF-155	17
C3 and C4 complement levels in AQP4-IgG-positive NMOSD and in MOGAD	16
Extracellular cardiolipin modulates microglial phagocytosis and cytokine secretion in a toll-like receptor (TLR) 4-dependent manner	16
Imbalance in T follicular helper cells producing IL-17 promotes pro-inflammatory responses in MuSK antibody positive myasthenia gravis	16
Laquinimod and 3,3′-diindolylemethane alleviate neuropathological events and neurological deficits in a mouse model of intracerebral hemorrhage	16
Free light chain kappa and the polyspecific immune response in MS and CIS – Application of the hyperbolic reference range for most reliable data interpretation	16
Depletion of microglia and macrophages with clodronate liposomes attenuates zymosan-induced Fos expression and hypothermia in the adult mouse	16
Crosstalk between gut microbiome and immunology in the management of ischemic brain injury	16
The association between systemic inflammation and cognitive performance in healthy adults	16
Peripheral blood expression levels of inflammasome complex components in two different focal epilepsy syndromes	16

Immunomodulatory effect and clinical outcome in Parkinson's disease patients on levodopa-pramipexole combo therapy: A two-year prospective study	16
Association between plasma neurofilament light chain levels and cognitive function in patients with Parkinson's disease	16
Sigma-1 receptor agonists as potential protective therapies in multiple sclerosis	15
Novel findings of HLA association with anti-LGI1 encephalitis: HLA-DRB1*03:01 and HLA-DQB1*02:01	15
Serum level of IL-1β in patients with inflammatory demyelinating disease: Marked upregulation in the early acute phase of MOG antibody associated disease (MOGAD)	15
HMGB1 plays an important role in pyroptosis induced blood brain barrier breakdown in diabetes-associated cognitive decline	15
GFAP IgG associated inflammatory polyneuropathy	15
The multifactorial roles of microglia and macrophages in the maintenance and progression of glioblastoma	15
Novel immune biomarkers in complex regional pain syndrome	15
Efficacy and safety of bortezomib in rituximab-resistant anti-N-methyl-d-aspartate receptor (anti-NMDAR) encephalitis as well as the clinical characteristics: An observational study	15
Bortezomib in anti-N-Methyl-d-Aspartate-Receptor (NMDA-R) encephalitis: A systematic review	15
Ferroptosis as a mechanism of oligodendrocyte loss and demyelination in experimental autoimmune encephalomyelitis	15
Potential autoimmune encephalitis following yellow fever vaccination: A report of three cases	15
Clinical features and diagnosis of neurosarcoidosis – review article	14
Central nervous system (CNS) inflammatory demyelinating diseases (IDDs) associated with COVID-19: A case series and review	14
The changing spectrum of antibody-mediated encephalitis in China	14
Interleukin-1β in peripheral monocytes is associated with seizure frequency in pediatric drug-resistant epilepsy	14
Epidemiology of neuronal surface antibody-mediated autoimmune encephalitis and antibody-based diagnostics	14
Low-dose rituximab lowers serum Exosomal miR-150-5p in AChR-positive refractory myasthenia gravis patients	14
Myelin oligodendrocyte glycoprotein-IgG associated disorders (MOGAD) following SARS-CoV-2 infection: A case series	14
12-months prospective Pentraxin-3 and metabolomic evaluation in multiple sclerosis patients treated with glatiramer acetate	14
Paraneoplastic cerebellar degeneration in a patient with breast cancer associated with carbonic anhydrase–related protein VIII autoantibodies	13
Hippocampal microglia CD40 mediates NPSLE cognitive dysfunction in mice	13
Glial fibrillary acidic protein (GFAP) associated autoimmune meningoencephalitis in a patient receiving nivolumab	13
Prognostic value of kappa free light chains determination in first-ever multiple sclerosis relapse	13
A bibliometric evaluation of the top 100 cited natalizumab articles	13
Innate immunity, inflammation activation and heat-shock protein in COVID-19 pathogenesis	13
Post-infectious rhombencephalitis after coronavirus-19 infection: A case report and literature review	13
Curcumin-loaded lipid-core nanocapsules attenuates the immune challenge LPS-induced in rats: Neuroinflammatory and behavioral response in sickness behavior	13
Correlation between elevated inflammatory cytokines of spleen and spleen index in acute spinal cord injury	13
Long-term cognitive and neuropsychiatric outcomes of anti-GABABR encephalitis patients: A prospective study	13
The ratio of prematurely aging to non-prematurely aging mice cohabiting, conditions their behavior, immunity and lifespan	13
Evidence for and against subclinical disease activity and progressive disease in MOG antibody disease and neuromyelitis optica spectrum disorder	13
Altered distributions and functions of natural killer T cells and γδ T cells in neonates with neonatal encephalopathy, in school-age children at follow-up, and in children with cerebral palsy	13
The neuroprotective effects and transdifferentiation of astrocytes into dopaminergic neurons of Ginkgolide K on Parkinson’ disease mice	13
Humoral immune response in convalescent COVID-19 people with multiple sclerosis treated with high-efficacy disease-modifying therapies: A multicenter, case-control study	12
Anti- RI antibody associated progressive supranuclear palsy like presentation in a patient with breast carcinoma	12
The AMPK pathway triggers autophagy during CSF1-induced microglial activation and may be implicated in inducing neuropathic pain	12
The role of human herpesvirus-6 and inflammatory markers in the pathogenesis of multiple sclerosis	12
Progression pattern of neurological disability with respect to clinical attacks in anti-MOG antibody-associated disorders	12
Selective modulation of trans-endothelial migration of lymphocyte subsets in multiple sclerosis patients under fingolimod treatment	12
Examination and characterisation of burst spinal cord stimulation on cerebrospinal fluid cellular and protein constituents in patient responders with chronic neuropathic pain - A Pilot Study	12
Attenuation of inflammatory response in the EAE model by PEGlated nanoliposome of pistachio oils	12
High levels of serum interleukin-6 are associated with disease activity in myasthenia gravis	12
Plasma levels of nerve growth factor in Egyptian autistic children: Relation to hyperserotonemia and autoimmunity	12
Lymphocyte-based ratios for predicting respiratory failure in Guillain-Barré syndrome	12
Assessing the role of a tissue-based assay in the diagnostic algorithm of autoimmune encephalitis	12
Seasonal variation in autoimmune encephalitis: A multi-center retrospective study	11
An interplay between immune response and neurodegenerative disease progression: An assessment using Drosophila as a model	11
The role of 5-HT2B-receptors in fluoxetine-mediated modulation of Th17- and Th1-cells in multiple sclerosis	11
Prognostic value of acute cerebrospinal fluid abnormalities in antibody-positive autoimmune encephalitis	11
Neuropathological spectrum in systemic lupus erythematosus: A single institute autopsy experience	11
Efficacy of plasma exchange in acute attacks of neuromyelitis optica spectrum disorders: A systematic review and meta-analysis	11
COVID-19 mRNA vaccine-associated encephalopathy, myocarditis, and thrombocytopenia with excellent response to methylprednisolone: A case report	11
TH17/Treg imbalance and IL-17A increase after severe aneurysmal subarachnoid hemorrhage	11
Peripheral neuropathy in sarcoidosis	11
Elevated levels of IL-32 in cerebrospinal fluid of neuro-Behcet disease: Correlation with NLRP3 inflammasome	11
Low-dose rituximab treatment for new-onset generalized myasthenia gravis	11
Glatiramer acetate increases T- and B -regulatory cells and decreases granulocyte-macrophage colony-stimulating factor (GM-CSF) in an animal model of multiple sclerosis	11
Covid-19 systemic infection exacerbates pre-existing acute disseminated encephalomyelitis (ADEM)	11
Antibodies to the α3 subunit of the ganglionic-type nicotinic acetylcholine receptors in patients with autoimmune encephalitis	10
The association between serum levels of TNF-α and IL-6 in schizophrenic patients and their metabolic status – A case control study	10
Programmed death protein 1 is essential for maintaining the anti-inflammatory function of infiltrating regulatory T cells in a murine spinal cord injury model	10
Genetic basis of Guillain-Barre syndrome	10
Brain astrocytes and microglia express functional MR1 molecules that present microbial antigens to mucosal-associated invariant T (MAIT) cells	10
Are sensory neurons exquisitely sensitive to interleukin 1β?	10
Microglial depletion exacerbates motor impairment and dopaminergic neuron loss in a 6-OHDA model of Parkinson's disease	10
Characterisation of the effects of pulsed radio frequency treatment of the dorsal root ganglion on cerebrospinal fluid cellular and peptide constituents in patients with chronic radicular pain: A rand	10
CNS demyelination with TNFα inhibitor exposure: A retrospective cohort study	10
Unilateral chronic pulsatile headache as the single manifestation of anti-MOG antibody-associated unilateral cerebral cortical encephalitis	10
Aging and the immune response in diabetic peripheral neuropathy	10
Sequential expression of neutrophil chemoattractants in cerebrospinal fluid after subarachnoid hemorrhage	10
The association between plasma HMGB1 and sRAGE and clinical outcome in intracerebral hemorrhage	10
Diminished functional properties of T regulatory cells in major depressive disorder: The influence of selective serotonin reuptake inhibitor	10
The combination of C C chemokine receptor type 5(CCR5) and Treg cells predicts prognosis in patients with ischemic stroke	10
Bilateral thalamic changes in anti-NMDAR encephalitis presenting with hemichorea and dystonia and acute transient psychotic disorder	10
Estriol in regulation of cell-mediated immune reactions in multiple sclerosis	9
Distinct cytokine profiles across trajectories of self-perceived cognitive impairment among early-stage breast cancer survivors	9
Seasonal variation of onset in patients with anti-aquaporin-4 antibodies and anti-myelin oligodendrocyte glycoprotein antibody	9
Neutrophil to-lymphocyte ratio as a possible predictor of prognosis in recently diagnosed multiple sclerosis patients	9

Guillain-Barré syndrome associated with SARS-CoV-2 infection: A case report with long term follow up	9
Intestinal permeability correlates with behavioural severity in very young children with ASD: A preliminary study	9
The association of genetic variants IL2RA rs2104286, IFI30 rs11554159 and IKZF3 rs12946510 with multiple sclerosis onset and severity in patients from Serbia	9
Humoral and cellular immunity in convalescent COVID-19 people with multiple sclerosis treated with ofatumumab	9
PARKIN modifies peripheral immune response and increases neuroinflammation in active experimental autoimmune encephalomyelitis (EAE)	9
Protection induced by estradiol benzoate in the MPP+ rat model of Parkinson's disease is associated with the regulation of the inflammatory cytokine profile in the nigro striatum	9
Dimethyl fumarate promotes B cell-mediated anti-inflammatory cytokine profile in B and T cells, and inhibits immune cell migration in patients with MS	9
Ponesimod modulates the Th1/Th17/Treg cell balance and ameliorates disease in experimental autoimmune encephalomyelitis	9
Anti-neurofilament antibodies and neurodegeneration: Markers and generators	9
Upregulation of interleukin (IL)-31, a cytokine producing CXCR1 peripheral immune cells, contributes to the immune abnormalities of autism spectrum disorder	9
Pretreatment neutrophil-to-lymphocyte/monocyte-to-lymphocyte ratio as prognostic biomarkers in glioma patients	9
Microglial proliferation attenuates sickness responses in adult mice during endotoxin-induced inflammation	9
Analysis of plasma protein biomarkers in childhood onset multiple sclerosis	9
Efficacy and safety of rituximab in relapsing-remitting multiple sclerosis: A systematic review and meta-analysis	9
A mucosal immune response induced by oral administration of heat-killed Mycobacterium avium subsp. paratuberculosis exacerbates EAE	9
Autoimmune glial fibrillary acidic protein astrocytopathy resembling isolated central nervous system lymphomatoid granulomatosis	9
Relationship of selective complement markers with schizophrenia	9
Complete Freund's adjuvant-free experimental autoimmune encephalomyelitis in Dark Agouti rats is a valuable tool for multiple sclerosis studies	8
IL-6 as a marker for NMOSD disease activity	8
Acute haemorrhagic leukoencephalitis (AHLE) – our experience and a short review	8
Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and	8
Opsoclonus-myoclonus syndrome associated with anti Kelch-like protein-11 antibodies in a young female patient without cancer	8
Comparison of clinical characteristics and prognoses in patients with different AQP4-Ab and MOG-Ab serostatus with neuromyelitis optica spectrum disorders	8
Doxycycline alleviates acute traumatic brain injury by suppressing neuroinflammation and apoptosis in a mouse model	8
Predictors of hypogammaglobulinemia and serious infections among patients receiving ocrelizumab or rituximab for treatment of MS and NMOSD	8
Involvement and relationship of bacterial lipopolysaccharides and cyclooxygenases levels in Alzheimer's Disease and Mild Cognitive Impairment patients	8
Papaverine provides neuroprotection by suppressing neuroinflammation and apoptosis in the traumatic brain injury via RAGE- NF-<kappa>B pathway	8
Repeated administration of LPS exaggerates amphetamine-induced locomotor response and causes learning deficits in mice	8
Elevated inflammatory proteins in cerebrospinal fluid from patients with painful knee osteoarthritis are associated with reduced symptom severity	8
B cell depletion changes the immune cell profile in multiple sclerosis patients: One-year report	8
LGI1-antibody associated epilepsy successfully treated in the outpatient setting	8
The clinical need for clustered AChR cell-based assay testing of seronegative MG	8
LRP4-IgG service line testing in seronegative myasthenia gravis and controls	8
L-methionine enhances neuroinflammation and impairs neurogenesis: Implication for Alzheimer's disease	8
Association between TNFA, IL10 and IL18 promoter gene variants and cognitive functions in patients with relapsing-remitting multiple sclerosis	8
Sub-basal increases of GABA enhance the synthesis of TNF-α, TGF-β, and IL-1β in the immune system organs of the Nile tilapia	8
Enterovirus A71 causing meningoencephalitis and acute flaccid myelitis in a patient receiving rituximab	8
The protective effects of neural stem cells and neural stem cells-conditioned medium against inflammation-induced prenatal brain injury	8
T cells show preferential adhesion to enteric neural cells in culture and are close to neural cells in the myenteric ganglia of Crohn's patients	7
Serum ROCK2, miR-300 and miR-450b-5p levels in two different clinical phenotypes of multiple sclerosis: Relation to patient disability and disease progression	7
Endocannabinoid system: Role in blood cell development, neuroimmune interactions and associated disorders	7
Expression analysis of NF-κB-associated long noncoding RNAs in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients	7
TREM2, microglial and ischemic stroke	7
IgG intrathecal synthesis in HIV-associated neurocognitive disorder (HAND) according to the HIV-1 subtypes and pattern of HIV RNA in CNS and plasma compartments	7
Post-stroke inflammatory response is linked to volume loss in the contralateral hemisphere	7
Rituximab as an effective therapeutic option in refractory Neuro-Behçet syndrome	7
Glioblastoma as an autoimmune limbic encephalitis mimic: A case and review of the literature	7
Autoimmune encephalitis misdiagnosis and mimics	7
Neuronal intermediate filament paraneoplastic autoimmunity complicating avelumab therapy of Merkel cell carcinoma	7
Relationships between cytokines and cognitive function from pre- to post-chemotherapy in patients with breast cancer	7
AChR-and MuSK-positive myasthenia gravis: Double trouble	7
Overcoming the challenges in diagnosis of AQP4-IgG positive neuromyelitis optica spectrum disorders in resource poor settings using an indigenized and cost effective cell based assay	7
Complex movement disorders in SARS-CoV-2 infection induced acute disseminated encephalomyelitis	7
Insomnia and depressive behavior of MyD88-deficient mice: Relationships with altered microglial functions	7
A paraneoplastic syndrome misdiagnosed as ALS: What are the red flags? A case report and review of the literature	7
Modelling multiple sclerosis using induced pluripotent stem cells	7
Characterization of cerebral small vessel disease by neutrophil and platelet activation markers using artificial intelligence	7
Immunological effects of dimethyl fumarate treatment in blood and CSF of patients with primary progressive MS	7
Rescue immunoadsorption treatment for neuromyelitis optica spectrum disorder attacks unresponsive to intravenous methylprednisolone	7
Corticosteroids lead to short-term improvement in cerebral amyloid angiopathy-related inflammation	7
Myelin oligodendrocyte glycoprotein (MOG) antibodies in a patient with glioblastoma: Red flags for false positivity	7